Association of Medical Device Preprocessors Applauds FDA Extension

Article

WASHINGTON, DC-The US Food and Drug Administration (FDA) has announced it will extend the application deadlines for premarket approval applications for certain reprocessed "single use" devices. The federal agency will also delay enforcement of the regulations affecting hospital reprocessors.

The Association of Medical Device Reprocessors (AMDR), a Washington, DC based trade association, represents the regulatory interest of third-party reprocessors of medical devices labeled for single use only. Pamela Furman, executive director of AMDR said the decision to postpone deadline date is the right decision, whether controversial or not.

"We applaud FDA for helping our nation's hospitals find ways to contain costs without jeopardizing the health and safety of patients," she said.

The controversy surrounds the Associations of Disposable Device Manufacturers (ADDM) disappointment in the deadline extension. ADDM officials said a recent death of a boy in the United Kingdom was related to medical equipment reprocessed incorrectly. They want the deadlines and enforcement to begin promptly.

The agency has released a statement saying officials will not begin regulating premarket requirements for ablation catheters until February, 14, 2002. This is the only action exception granted by FDA concerning active enforcement of premarket approval for all reprocessed Class III devices. Third-party reprocessing of Class II and Class I devices will be phased in during the next 12 months.

For the entire FDA statement, visit: www.fda.gov/bbs/topics/ANSWERS/2001/ANS01098.html.

Information from the Association of Medical Device Reprocessors

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content